Cargando…
Multiple Target-Specific Molecular Imaging Agents Detect Liver Cancer in a Preclinical Model
Liver cancer is the fifth most common cause of cancer deaths worldwide. Noninvasive diagnosis is difficult and the disease heterogeneity reduces the accuracy of pathological assays. Improvement in diagnostic imaging of specific molecular disease markers has provided hope for accurate and early nonin...
Autores principales: | Ke, S, Zhang, F, Wang, W, Qiu, X, Lin, J, Cameron, AG, Zou, C, Gao, X, Zau, C, Zhu, VF, Li, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428706/ https://www.ncbi.nlm.nih.gov/pubmed/22779431 http://dx.doi.org/10.2174/156652412802480952 |
Ejemplares similares
-
Multiple Target-Specific Molecular Agents for Detection and Image Analysis of Breast Cancer Characteristics in Mice
por: Ke, S, et al.
Publicado: (2013) -
Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis
por: Wall, Jonathan S., et al.
Publicado: (2015) -
In vivo molecular imaging in preclinical research
por: Kim, Su Jin, et al.
Publicado: (2022) -
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents
por: Neri, E., et al.
Publicado: (2015) -
Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer
por: Chen, Wei, et al.
Publicado: (2017)